fda tirzepatide decision approves new weight-loss drug Zepbound (tirzepatide) FDA's GLP-1 decision kicks off

We found that participants with higher BMI at baseline were more likely to be female, had more volume overload and greater HF symptom severity, and had more severe systemic inflammation at the time of enrollment

Because of rising Type 2 diabetes and obesity rates around the globe, semaglutide use is skyrocketing

metoclopramide should be used cautiously and only short-term, as it can interfere with weight loss goals

Inject slowly down the vial wall to minimize foaming

If you are in Chandler, AZ, and have been looking for an effective weight loss solution, its time to try GLP-1 medications

These could signal thyroid changes or indicate that your dose needs adjustment